drugset / Trial / NCT02404363
Safety and Efficacy of Clopidogrel in Locally Advanced and Metastatic Pancreatic Adenocarcinoma Treated With Chemotherapy
Phase 3
Terminated
39 enrolled
Assistance Publique - Hôpitaux de Paris
Groupe Francophone Thrombose et Cancer · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
Clopidogrel has been shown to slow down tumor progression in orthoptic pancreatic murine tumor. In a pilot study, the rate of microparticles was correlated with response rate of pancreatic adenocarcinoma. The aim of the study is; * to compare the phenotypes of coagulation, the tumor progression and metastasis formation with and without clopidogrel treatment in association with chemotherapy in advanced pancreatic cancer patients * to correlate the decrease of microparticles levels after one month of chemotherapy with tumor response (ancillary study)
Timeline
- Start
- 2016-01-11
- Primary completion
- 2017-12-04
- Completion
- 2018-03-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clopidogrel | Small molecule | 75 mg | — |